Designed for busy clinicians, this program provides

the key take-aways and practice-changing presentations from SABCS 2024.

Registration Fees: 

Physician : $50 USD

Industry: $250 USD

For group subscription pricing contact: 

goldstandard@encoremeded.com
 

Intended Audience

This official Best of SABCS program is directed to practicing oncologists (medical, surgical, radiation), community physicians, medical residents and fellows training in oncology, as well as other pertinent healthcare professionals involved in oncology medicine.

Learning Objectives

After completion of this program, attendees should be able to:

  • APPLY evidence-based strategies for preventing, detecting, and diagnosing breast cancer in at-risk patients.
  • CONDUCT biomarker and genetic testing in patients with breast cancer using evidence-based principles to identify actionable mutations and other tumor    characteristics that influence treatment approaches.
  • INCORPORATE new results from preclinical research and clinical trials in all aspects of breast cancer care presented during oral, poster and educational sessions at the annual San Antonio Breast Cancer Symposium into clinical practice.
  • INTEGRATE new data from clinical trials of novel therapeutics in breast cancer into local treatment patterns to align current practices with evidence based approaches, overcome resistance mechanisms, and enhance patient outcomes.
  • DESIGN treatment plans for patients with breast cancer using individualized treatment strategies based on breast cancer subtype, clinical characteristics, and patient preferences and goals to optimize therapy.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The UT Health Science Center San Antonio and Encore Medical Education. The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

The UT Health Science Center San Antonio designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Duration: 

Release: February 12, 2025

Expiration:  November 1, 2025

Commercial Support

This  program is supported by unrestricted educational grants from: 

AstraZeneca, Daiichi Sankyo, Exact Sciences, Pfizer, Stemline/Menarini, and Puma Biotechnology

Agenda

Name Speakers Total Minutes Credits
Wednesday, February 12, 2025
New Directions in Breast Cancer Prevention and Approaches to Risk ReductionMili AroraMili Arora, UC Davis Comprehensive Cancer Center29:03AMA PRA Category 1 Credits™ (.50 hour)
Insights in Translational Research and Resistance MechanismsMark PegramMark Pegram, Stanford University School of Medicine34:53AMA PRA Category 1 Credits™ (.50 hour)
Advances in Approaches to Local-Regional Disease (Surgical and Radiation)Rita MukhtarRita Mukhtar, UCSF30:41AMA PRA Category 1 Credits™ (.50 hour)
Clinical Cases and Panel Discussion - Part 1Hope RugoHope Rugo, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center32:35AMA PRA Category 1 Credits™ (.50 hour)
Updates in the Management of HR+ Early Stage DiseaseHelen ChewHelen Chew, UC Davis Comprehensive Cancer Center28:50AMA PRA Category 1 Credits™ (.50 hour)
Updates in Management of HR+ Metastatic DiseaseRebecca ShatskyRebecca Shatsky, UC San Diego Moores Cancer Center29:51AMA PRA Category 1 Credits™ (.50 hour)
Updates in the Management of Triple Negative DiseaseJo ChienJo Chien, UCSF Helen Diller Family Comprehensive Cancer Center28:47AMA PRA Category 1 Credits™ (.50 hour)
Updates in Management of HER2+ DiseaseMelinda TelliMelinda Telli, Stanford University School of Medicine33:23AMA PRA Category 1 Credits™ (.50 hour)
Clinical Cases and Panel Discussion - Part 2Hope RugoHope Rugo, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center55:21AMA PRA Category 1 Credits™ (1.0 hour)

Disclaimers

The opinions and comments expressed by faculty and other experts, whose input is included in this program, are their own. This enduring material is produced for educational purposes only. Please review complete prescribing information of specific drugs mentioned in this program including indications, contraindications, warnings, and adverse effects and dosage before administering to patients.

This material may not be published, broadcast, rewritten, or redistributed in any form without prior authorization from Encore Medical Education. Your use of this website constitutes acceptance of Encore Medical Education's  Privacy Policy and Terms & Conditions.